Disorders of Sex Development.
2021
1. Alejandro Diaz, MD*,†
2. Elizabeth G. Lipman Diaz, PhD, ARNP, CPNP‡
1. *Nicklaus Children’s Hospital, Miami, FL
2. †Herbert Wertheim College of Medicine, Florida International University, Miami, FL
3. ‡University of Miami School of Nursing and Health Studies, Coral Gables, FL
* Abbreviations:
AMH: : anti-mullerian hormone
CAH: : congenital adrenal hyperplasia
CAIS: : complete androgen insensitivity
CYP21A2: : 21-hydroxylase
CYP11B1: : 11β-hydroxylase type 1
DHEA: : dehydroepiandrosterone
5α-DHT: : 5α-dihydrotestosterone
DSD: : disorder of sex development
EMS: : external masculinization score
FSH: : follicle-stimulating hormone
HCG: : human chorionic gonadotropin
3β-HSD2: : 3β- hydroxysteroid dehydrogenase/isomerase type 2
17β-HSD3: : 17β-hydroxysteroid dehydrogenase type 3
LH: : luteinizing hormone
NR5A1: : nuclear receptor subfamily 5 group A, member 1
17-OHP: : 17-hydroxyprogesterone
PAIS: : partial androgen insensitivity
5α-RD2: : 5α-reductase type 2
WT1 : : Wilms tumor suppressor gene
Traditionally, ambiguous genitalia have been defined as a “medical and social emergency”; however, it is not. It requires a systematic, team-oriented approach.
Access to genetic testing and molecular diagnosis permits better understanding of conditions that produce ambiguous genitalia and allows better planning for gender assignment and further care.
After completing this article, readers should be able to:
1. Identify the most common causes of ambiguous genitalia in infants.
2. Understand basic imaging and laboratory tests for diagnosis.
3. Recognize the complexity of gender assignment and the need to partner with other medical specialties and the family for decision-making.
4. Recognize conditions that need immediate pharmacologic treatment to avoid medical complications.
Disorders of sex development (DSDs), a vastly heterogeneous array of innate conditions, are secondary to abnormal development of sex chromosomes, as well as atypical growth of the gonads and genital anatomy. Specifically, DSDs result from insufficient virilization of the genitalia in a 46,XY fetus due to disorders of gonadal development, abnormal androgen synthesis, or disorders of androgen action, or secondary to the masculinization of the genitals of a 46,XX fetus. There is broad phenotypic expression of DSDs, ranging from minor variations of gonadal function and genital appearance to severely atypical gonads and genitalia.
The incidence of ambiguous genitalia at birth is estimated to be 1:4,500 to 1:5,500. (1) Among 46,XY individuals, the incidence of DSDs has been estimated to be 1:20,000 births; however, cryptorchidism and hypospadias are common congenital anomalies, occurring in 1:200 to 1:300 newborns. (1) Among 46,XX individuals, the most common cause of DSDs is congenital adrenal hyperplasia (CAH), which occurs in 1:14,000 to 1:15,000 live births. (1)
Prenatal karyotype evaluation as part of cell-free DNA testing is now common. Conditions such as complete androgen insensitivity (CAIS) or complete gonadal dysgenesis were often missed at birth or during infancy and childhood, …
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
35
References
0
Citations
NaN
KQI